Statistician testifies Johnson & Johnson's branded products had small share of Oklahoma's opioid market

UTC
US NEWS FEEDS > OKLAHOMA >

By Randy EllisStaff writerrellis@oklahoman.comNORMAN — Johnson & Johnson's branded opioid products appeared to make up only a small fraction of Oklahoma's opioid market, a professor of applied mathematics and statistics testified Thursday. Testifying for the defense, M. Laurentius Marais, who received his PhD from Stanford, told a Cleveland County District Court judge that he conducted detailed analyses of several large computer databases and found that prescriptions for Johnson & Johnson's Duragesic fentanyl patches and Nucynta opioid tablets made up only 0.82 percent of the prescriptions filled through the state's SoonerCare Medicaid program from 1996-2017, 0.20 percent of the prescriptions filled by Blue Cross/Blue Shield from 2008 through 2017,...

READ MORE >
Statistician testifies Johnson & Johnson's branded products had small share of Oklahoma's opioid market

Sponsored Content